Phase I. Trial of irinotecan and temozolomide in patients with solid tumors.

Oncology (Williston Park, N.Y.)

Volumn 17, Issue 5 Suppl 5, 2003, Pages 41-45

  Jones, Suzanne F ^a   Gian, Victor G ^a   Greco, F Anthony ^a   Miranda, Fernando T ^a   Shipley, Dianna L ^a   Thompson, Dana S ^a   Hainsworth, John D ^a   Toomey, Mitchell A ^a   Willcutt, Noel T ^a   Burris 3rd , Howard A ^a  

^a SARAH CANNON RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DACARBAZINE; DRUG DERIVATIVE; IRINOTECAN; TEMOZOLOMIDE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; FEMALE; HUMAN; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; NEOPLASM; PHASE 1 CLINICAL TRIAL; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; DACARBAZINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; NEOPLASMS; TREATMENT OUTCOME;

EID: 0141783773     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)